11-59422313-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001001954.2(OR5A2):c.641T>A(p.Val214Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000539 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001954.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5A2 | NM_001001954.2 | c.641T>A | p.Val214Glu | missense_variant | Exon 2 of 2 | ENST00000302040.6 | NP_001001954.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5A2 | ENST00000302040.6 | c.641T>A | p.Val214Glu | missense_variant | Exon 2 of 2 | 6 | NM_001001954.2 | ENSP00000303834.4 | ||
OR5A2 | ENST00000641361.1 | c.641T>A | p.Val214Glu | missense_variant | Exon 2 of 2 | ENSP00000493065.1 | ||||
OR5A2 | ENST00000641673.1 | c.641T>A | p.Val214Glu | missense_variant | Exon 1 of 1 | ENSP00000492975.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251044Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135644
GnomAD4 exome AF: 0.0000588 AC: 86AN: 1461840Hom.: 0 Cov.: 34 AF XY: 0.0000385 AC XY: 28AN XY: 727214
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.641T>A (p.V214E) alteration is located in exon 1 (coding exon 1) of the OR5A2 gene. This alteration results from a T to A substitution at nucleotide position 641, causing the valine (V) at amino acid position 214 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at